| Literature DB >> 1605284 |
Abstract
Because oral contraceptives are used by tens of millions of healthy women, their safety for short-term and long-term use is an important issue that has been examined in a large number of epidemiologic studies. These studies have become more rigorous and have increased in size and analytic sophistication over the years. Although breast cancer remains the most important safety concern, the bulk of recent data suggests that oral contraceptives have no overall impact on a woman's risk of developing this disease. The results are less clear on the risk of cervical cancer and its precursors because of methodologic problems. However, the newer oral contraceptive formulations no longer appear to be associated with an increased risk of myocardial infarction or stroke.Entities:
Keywords: Americas; Behavior; Biology; Breast Cancer; Cancer; Cardiovascular Effects; Cervical Cancer; Contraception; Contraceptive Methods--beneficial effects; Contraceptive Methods--side effects; Developed Countries; Developing Countries; Diseases; Dysmenorrhea; Epidemiologic Methods; Europe; Evaluation; Family Planning; Hemic System; Hemoglobin Level; Infections; Infertility; Literature Review; Liver Neoplasms; Menstruation Disorders; Neoplasms; Neoplasms, Benign; North America; Northern America; Northern Europe; Oral Contraceptives--beneficial effects; Oral Contraceptives--side effects; Ovarian Cancer; Ovarian Cysts; Pelvic Infections; Physiology; Pregnancy Complications; Pregnancy, Ectopic; Reproduction; Research Methodology; Risk Assessment; Smoking; United Kingdom; United States
Mesh：
Substances：
Year: 1992 PMID： 1605284 DOI： 10.1016/0002-9378(92)91394-p
Source DB: PubMed Journal: Am J Obstet Gynecol ISSN： 0002-9378 Impact factor: 8.661